Community Support Program for Lung Cancer Screening

NCT06207435 | Completed Results

• 2 other identifiers: UPCC 07523852598
• Study Type: interventional
• Target: 242
• Locations: 1 country
• Sites: 1

Brief Summary

The research study aims to create a program for lung cancer screening attendance

Conditions

Lung Cancer; Behavior

Keywords

screening adherence

Outcome Measures

Primary Outcomes (1)

• Percentage of Scheduled Lung Cancer Screening Appointments Attended by Participants

  The Primary Outcome measures the rate of appointment attendance across three groups: West Philadelphia CSP Participants (eligible West Philadelphia residents who opted into the CSP), West Philadelphia Non CSP Participants (eligible West Philadelphia residents who did not opt into the CSP), and Southwest Philadelphia Residents (patients who did not receive an option to participate in the CSP).

  12 months

Secondary Outcomes (1)

• Percentage of CSP Enrollment

  12 months

Study Arms (2)

West Philadelphia Residents

EXPERIMENTAL

For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions

Behavioral: Transportation

Non West Philadelphia Residents

NO INTERVENTION

For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.

Interventions

Transportation BEHAVIORAL

Eligible patients are contacted and offered free transportation to and from their upcoming appointment.

West Philadelphia Residents

Eligibility Criteria

• Age: 18 Years - 89 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Upcoming or missed follow-up LDCT (low dose CT)
• West Philadelphia resident
• Between 18-89 years' old

You may not qualify if:

• No upcoming LDCT
• Lives outside West Philadelphia
• Outside age range

Sponsors & Collaborators

• Abramson Cancer Center at Penn Medicine: lead

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Lung Neoplasms; Behavior

Interventions

Transportation

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Technology, Industry, and Agriculture

Results Point of Contact

• Title: Dr. Farouk Dako
• Organization: University of Pennsylvania

farouk.dako@pennmedicine.upenn.edu

2673091241

Study Officials

• Farouk Dako, MD, MPH

  University of Pennsylvania

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 20, 2023
• First Posted: January 17, 2024
• Study Start: February 10, 2023
• Primary Completion: August 12, 2024
• Study Completion: August 30, 2024
• Last Updated: September 2, 2025
• Results First Posted: September 2, 2025

Record last verified: 2025-08

Locations

US (1)